Linganisha mbinu
Pitia mbinu ulizochagua bega kwa bega; safu zinazotofautiana zinaangaziwa.
| Kipimo cha Udhibiti wa Pumu (Asthma Control Test - ACT)× | Hojaji ya Ugonjwa wa Parkinson-39× | |
|---|---|---|
| Nyanja | Matokeo ya Afya | Matokeo ya Afya |
| Familia | Process / pipeline | Process / pipeline |
| Mwaka wa asili≠ | 2004 | 1997 |
| Mwanzilishi≠ | Robert A. Nathan et al. | Crispin Jenkinson et al. |
| Aina≠ | Self-report symptom control questionnaire | Self-report quality of life questionnaire |
| Chanzo asilia≠ | Nathan, R. A., Sorkness, C. A., Kosinski, M., Schatz, M., Li, J. T., Marcus, P., ... & Pendergraft, T. B. (2004). Development of the asthma control test: A survey for assessing asthma control in children and adults. Allergy and Asthma Proceedings, 25(1), 1-6. DOI ↗ | Jenkinson, C., Fitzpatrick, R., Peto, V., Greenhall, R., & Hyman, N. (1997). The Parkinson's Disease Questionnaire (PDQ-39): Development and validation of a Parkinson's disease summary index score. Age and Ageing, 26(5), 353-357. DOI ↗ |
| Majina mbadala | ACT, Asthma Control Test, Asthma Control Assessment | PDQ-39, Parkinson's Disease Questionnaire, PDQ |
| Zinazohusiana | 4 | 4 |
| Muhtasari≠ | The ACT is a simple, rapid, patient-centered measure of asthma control. Developed by Robert Nathan and colleagues in 2004, this 5-item questionnaire quantifies how asthma symptoms, activity limitation, and nighttime awakening affect daily life. It is the most widely used asthma control measure in clinical practice and is recommended by major asthma guidelines as a standard assessment tool. | The PDQ-39 is the most widely used patient-reported outcome measure for Parkinson's disease quality of life. Developed by Crispin Jenkinson and colleagues in 1997, this 39-item self-report questionnaire comprehensively assesses how Parkinson's symptoms affect daily functioning, emotional well-being, stigma, social support, and cognitive-communication abilities. It is the recommended instrument in major Parkinson's disease clinical trials and forms a core component of outcome measurement in movement disorders. |
| ScholarGateSeti ya data ↗ |
|
|